Live GMAT classes with Target Test Prep start Nov 21 and Nov 22. First class free.

See classes
Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

Newsweek Readers’ Choice Awards 2026 winner: Target Test Prep, #1 Test Prep

Target Test Prep was voted #1 Best Test Prep in the 2026 Newsweek Readers’ Choice™ Awards.

★★★★★5.0563 reviews
GMATLiveTeachStarts Nov 22
Josh Braslow, Target Test Prep GMAT expert
LIVE ONLINE CLASSES

Get Ready for GMAT Test Day Faster with Live Online Classes

with Josh Braslow, 20+ years in test prep

Nov 22 · Josh Braslow
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes + 6 months of TTP OnDemand
  • Attend the first class for free
  • Every class is recorded, so you never fall behind
View classes & enroll
Limited seats availableTarget Test Prep
EALiveTeachOnDemandStart anytime
EXECUTIVE ASSESSMENT

Target Test Prep EA OnDemand

Self-paced EA prep. Study on your schedule.

EXECUTIVE ASSESSMENT

with

165+ EA score guarantee
$05-day trial no automatic billing
Schedule
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll Start free 5-day trial
Limited cohort · enrollment openTrial includes full course accessTarget Test Prep
GMATOnDemandStart anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Pharmaceutical companies spend more than ever on research an

Expert replies
by BTGmoderatorDC » Sat Oct 05, 2019 4:13 pm
Pharmaceutical companies spend more than ever on research and development; yet the number of new drugs patented each year has dropped since 1963. At the same time, profits—at constant 1963 dollars—for the industry as a whole have been steadily increasing.

Which of the following, if true, is the single factor most likely to explain, at least in part, the three trends mentioned above for money spent, drugs patented, and profits made?

A. Government regulations concerning testing requirements for novel drugs have become steadily more stringent.

B. Research competition among pharmaceutical companies has steadily intensified as a result of a general narrowing of research targets to drugs for which there is a large market.

C. Many pharmaceutical companies have entered into collaborative projects with leading universities, while others have hired faculty members away from universities by offering very generous salaries.

D. The number of cases in which one company's researchers duplicated work done by another company's researchers has steadily grown.

E. The advertising budgets of the major pharmaceutical companies have grown at a higher rate than their profits have.

OA B

Source: Official Guide
Join the discussion
Source: — Critical Reasoning |

by deloitte247 » Sun Oct 13, 2019 2:24 pm
Conclusion: Pharmaceutical companies spend more than ever on research and development. However, the number of new drugs patented each year dropped since 1963 as well as the profits at constant 1963 dollars have been increasing steadily.

Option A - Incorrect
Government intervention concerning testing requirement for nove; drugs is not in harmony with the argument. Hence, we are not concerned about this claim.

Option B - Correct
This explains the argument because the pharmaceutical companies spend more than ever on research and development. Nevetheless, there has been a drop in new drugs patented since 1963, while the profits has been increasing alongside.

Option C - Incorrect
We can't know from the passage if pharmaceutical companies collaborated with leading universities or hire faculty members. This claim is unfounded.

Option D - Incorrect
This is not relevant to the argument because no record of duplication was stated in the passage.

Option E - Incorrect
There is no concrete evidence to back this up. No information was given about the rate of advertising budget of pharmaceutical companies.
Join the discussion